Come up with a name for your new list and we'll add to it:
Callidus Biopharma was acquired by
Amicus Therapeutics on November 21, 2013.
Callidus Biopharma is a development-stage biotechnology company focused on developing superior drugs for rare and ultra-rare diseases. Specifically, the company is focused on discovering and developin…